EXCALIBER - Maintenance

A Phase 3, Two-stage, Randomized, Multi-center, Controlled, Open-label Study Comparing Iberdomide Maintenance to Lenalidomide Maintenance Therapy After Autologous Stem Cell Transplantation (ASCT) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) (EXCALIBER-Maintenance)

Near Add Your Location

Sorting 43 by

New York University Langone Medical Center
Laura and Isaac Perlmutter Cancer Center
New York, NY
  • Accepting patients
  • Show Principal Investigator
Willamette Valley Cancer Institute (Eugene)
Eugene, OR
  • Accepting patients
  • Show Principal Investigator
Winship Cancer Institute
Emory University
Atlanta, GA
  • Accepting patients
  • Show Principal Investigator
Novant Health Presbyterian Medical Center
Novant Health
Charlotte, NC
  • Accepting patients
  • Show Principal Investigator
University Cancer and Blood Center
Athens, GA
  • Accepting patients
  • Show Principal Investigator
Cleveland Clinic - Taussig Cancer Center
Taussig Cancer Institute
Cleveland, OH
  • Accepting patients
  • Show Principal Investigator
Herbert Irving Comprehensive Cancer Center (Columbia University)
Columbia University Medical Center
New York, NY
  • Accepting patients
  • Show Principal Investigator
Cleveland Clinic Florida
Weston, FL
  • Accepting patients
  • Show Principal Investigator
Oncology Hematology Care Inc. (Kenwood)
Cincinnati, OH
  • Accepting patients
  • Show Principal Investigator

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print this trial to share with your doctor.

(888) 788-8038

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.